- Home
- CLLS vs FINW Comparison
CLLS vs FINW Comparison
Compare CLLS & FINW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- FINW
- Stock Information
- Founded
- CLLS 1999
- FINW 1999
- Country
- CLLS France
- FINW United States
- Employees
- CLLS N/A
- FINW N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- FINW Commercial Banks
- Sector
- CLLS Health Care
- FINW Finance
- Exchange
- CLLS Nasdaq
- FINW Nasdaq
- Market Cap
- CLLS 240.2M
- FINW 211.4M
- IPO Year
- CLLS 2007
- FINW 2021
- Fundamental
- Price
- CLLS $1.87
- FINW $17.68
- Analyst Decision
- CLLS Buy
- FINW Buy
- Analyst Count
- CLLS 3
- FINW 2
- Target Price
- CLLS $7.00
- FINW $17.50
- AVG Volume (30 Days)
- CLLS 93.0K
- FINW 17.7K
- Earning Date
- CLLS 11-04-2024
- FINW 10-24-2024
- Dividend Yield
- CLLS N/A
- FINW N/A
- EPS Growth
- CLLS N/A
- FINW N/A
- EPS
- CLLS N/A
- FINW 1.06
- Revenue
- CLLS $36,042,000.00
- FINW $69,238,000.00
- Revenue This Year
- CLLS $271.02
- FINW N/A
- Revenue Next Year
- CLLS $33.48
- FINW $10.71
- P/E Ratio
- CLLS N/A
- FINW $16.71
- Revenue Growth
- CLLS 46.96
- FINW 4.86
- 52 Week Low
- CLLS $1.70
- FINW $8.72
- 52 Week High
- CLLS $3.77
- FINW $17.98
- Technical
- Relative Strength Index (RSI)
- CLLS 47.58
- FINW 74.77
- Support Level
- CLLS $1.70
- FINW $17.49
- Resistance Level
- CLLS $2.00
- FINW $17.98
- Average True Range (ATR)
- CLLS 0.11
- FINW 0.56
- MACD
- CLLS 0.02
- FINW 0.03
- Stochastic Oscillator
- CLLS 56.67
- FINW 84.94
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.
About FINW FinWise Bancorp
FinWise Bancorp is an independent bank that provides a full range of banking services to individual and corporate customers. The bank's primary source of revenue is from loans including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank also has established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.